Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer
Stocks in this Quantisnow insightHealth Care
Historical context for COR
Across the 16 sessions after earlier COR headlines, the stock closed higher 9 times and lower 7 times, with a median move of 1.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | COR | SPY |
|---|---|---|---|
| May 22, 2026 | Cencora Announces Updated Fiscal Year 2026 Financial Outlook | +3.6% | +0.4% |
| May 6, 2026 | Cencora Reports Fiscal 2026 Second Quarter Results | -17.4% | +1.4% |
| Apr 28, 2026 | William Blair initiated coverage on Cencora | +0.6% | -0.5% |
| Apr 2, 2026 | Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release | +2.2% | +0.1% |
| Mar 23, 2026 | Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners' Retina Business | -1.9% | +1.1% |
| Mar 17, 2026 | Cencora Announces Financial Leadership Transition | -3.2% | +0.3% |
Quantisnow market dataNYSE
COR
Cencora Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
Get push alerts for COR
Full COR profile on Quantisnow Follow COR and get a push notification the moment its next story breaks.